REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Dec 2016 14:45

RNS Number : 9971Q
ABCAM Plc
05 December 2016
 

 

For immediate release

5 December 2016

ABCAM PLC

("Abcam" or the "Company")

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, was notified on 2 December that Jim Warwick, Executive Director of the Company, on 2 December 2016 exercised options over 30,000 ordinary shares ("Ordinary Shares") of 0.2 pence each in the Company at an exercise price of 0.2 pence per share, and subsequently sold the resulting Ordinary shares at £8.08375 per share.

As a result of the transaction described above, Jim Warwick's total interest in the Company remains at 2,881,381 Ordinary Shares.

The notification for Mr Warwick can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

##Ends##

 

For further information, please contact:

Abcam

+ 44 (0) 1223 696 000

Suzanne Smith, Company Secretary

 

J.P.Morgan Cazenove - Nominated Advisor & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Christopher Cargill

FTI Consulting

+ 44 (0) 20 3727 1000

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David James Warwick

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Exercise of share options at an exercise price of 0.2 pence per share and sale of resulting ordinary shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.08375

30,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

30,000

£8.08375

£242,512.50

f)

Date of the transaction

2 December 2016

g)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZELFBQLFZFBB
Date   Source Headline
9th Dec 20162:56 pmRNSDirector/PDMR Shareholding
8th Dec 20165:09 pmRNSDirector/PDMR Shareholding
5th Dec 20162:45 pmRNSDirector/PDMR Shareholding
1st Dec 20164:01 pmRNSTotal Voting Rights
10th Nov 20162:00 pmRNSApplication for admission to trading
10th Nov 20167:00 amRNSAxioMx technology milestones accelerated
7th Nov 201611:21 amRNSDirector/PDMR Shareholding
7th Nov 20169:30 amRNSDirector/PDMR Shareholding
2nd Nov 20164:22 pmRNSResult of AGM
2nd Nov 20167:00 amRNSAGM Statement
1st Nov 20163:02 pmRNSTotal Voting Rights
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSNew facility at Cambridge Biomedical Campus
3rd Oct 20161:07 pmRNSTotal Voting Rights
3rd Oct 20167:00 amRNSDirector/PDMR Shareholding
28th Sep 20168:43 amRNSDirector/PDMR Shareholding
26th Sep 20167:19 amRNSAnnual Financial Report
21st Sep 20167:00 amRNSHolding(s) in Company
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
15th Sep 20162:25 pmRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSPreliminary Results
2nd Sep 20167:00 amRNSApplication for admission to trading
24th Aug 20167:00 amRNSNotice of Results
23rd Aug 20163:01 pmRNSBlock listing Interim Review
3rd Aug 20167:00 amRNSDirectorate Change
1st Aug 20161:11 pmRNSTotal Voting Rights
25th Jul 20167:00 amRNSPre-Close Period Update
1st Jul 20162:12 pmRNSTotal Voting Rights
20th Jun 20167:00 amRNSAbcam to appoint Gavin Wood as CFO
1st Jun 20164:38 pmRNSTotal Voting Rights
3rd May 20162:03 pmRNSTotal Voting Rights
19th Apr 20162:35 pmRNSDirector/PDMR Shareholding
1st Apr 20161:50 pmRNSTotal Voting Rights
24th Mar 20162:29 pmRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSPosting of Half Yearly Report
22nd Mar 20169:33 amRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSDirectorate Change
7th Mar 20167:00 amRNSHalf Yearly Report
10th Feb 201610:59 amRNSNotice of Results
8th Feb 20163:58 pmRNSBlocklisting Interim Review
1st Feb 20162:06 pmRNSTotal Voting Rights
29th Jan 20163:09 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSHalf Year Trading Update
4th Jan 20163:02 pmRNSTotal Voting Rights
7th Dec 20153:57 pmRNSDirector/PDMR Shareholding
7th Dec 20151:59 pmRNSDirector/PDMR Shareholding
1st Dec 20154:30 pmRNSTotal Voting Rights
12th Nov 20153:22 pmRNSApplication for admission to trading - update
12th Nov 20152:56 pmRNSDirector/PDMR Shareholding
11th Nov 20154:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.